FDA Leadership Calls for LDT Reforms
While championing advances made in diagnostic technology in recent years, top officials from the US Food and Drug Administration (FDA) are calling for a new regulatory framework for in vitro clinical tests (IVCTs) and laboratory developed tests (LDTs). Background Since 2013, FDA has attempted to develop a new regulatory framework for…